LSD-based pill reduces anxiety in late-stage trial, says Definium
Definium Therapeutics said its LSD-based experimental pill, DT120, significantly reduced anxiety symptoms in a 214-patient late-stage trial. Patients with generalised anxiety disorder who received a single 100-microgram dose showed an 11.6-point drop…
